Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
GTCbio Announces Its 4th International Stem Cell Research & Therapeutics Conference
GTCbio announces the 4th International Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA – featuring a keynote presentation from the Rudolf Jaenisch, a Founding Member of Whitehead Institute, a pioneer of transgenic science, and a leader in the field of therapeutic cloning, also called nuclear transfer. - January 26, 2008 - GTCbio
Chief Scientist at the NCI to Speak at 3rd Imaging in Drug Development Conference - March 17-18, San Diego
Dr. Hisataka Kobayashi, Chief Scientist of Molecular Imaging at the National Cancer Institute will speak at GTCbio’s 3rd Imaging in Pre-clinical & Clinical Drug Development conference March 17-18, 2008 in San Diego, CA. Dr. Kobayashi will discuss environment sensitive "smart"... - January 26, 2008 - GTCbio
Director of NIBIB to Give Keynote Talk at 3rd Imaging in Drug Development Conference – Mar. 17-18, San Diego
Roderic Pettigrew, Director at the National Institute of Biomedical Imaging & Bioengineering, NIH will give the keynote presentation at GTCbio’s 3rd Imaging in Drug Development conference March 17-18, 2008 in San Diego, CA. Dr. Pettigrew will discuss the importance of imaging in 21st... - January 26, 2008 - GTCbio
Sanofi-Aventis to Present at GTCbio’s 4th Stem Cell Research & Therapeutics- April 17-18, Boston
Dr. Christophe Labie, Group Leader of the Molecular Neurobiology Group at Sanofi-Aventis will give a presentation entitled “Stimulation of Brain Neurogenesis: A Way to Replace Neuron Loss in Diseased or Injured Brain” at GTCbio’s 4th Stem Cell Research & Therapeutics on April... - January 24, 2008 - GTCbio
Anavex Outlines Corporate Milestones, Drug Advancement Plans for 2008
Anavex Life Sciences Corp. achieved significant development of its lead drug candidates and growth of its management and scientific teams during 2007. - January 24, 2008 - Anavex Life Sciences Corp.
Octagon to Present at 21st Annual DIA Conference for Electronic Document Management
Company Thought Leaders Participate in Programming and Presentations. - January 24, 2008 - Octagon Research Solutions, Inc
AdvantaPure(R) Introduces Single Use Process Systems for the Pharmaceutical Industry
Cost-saving Single Use Process Systems of silicone tubing, molded silicone components, and parts such as bags and bottles are now available from AdvantaPure. The systems reduce contamination risks, simplify cleaning procedures, and offer design flexibility. Tubing and components are cleanroom manufactured and assembled. Gamma irradiatable RFID tags may be attached to systems for reliable electronic identification. - January 24, 2008 - NewAge Industries, Inc.
Anatstat Health Education Media Promotes and Expands
Anatstat Health Education Media, a health education company that specializes in developing interactive patient education materials, announced today that Jonas Tolliver and Scott Romer have accepted positions as Account Executives. Mr. Tolliver comes to Anatstat with over 5 years of successful... - January 22, 2008 - Anatstat USA Health Education Media
Testing Laboratory Software for Pharmaceutical & Chemical Industries
Marg Compusoft Pvt. Ltd. an ISO Certified Company and a computer software provider, especially for Pharmaceuticals & Chemicals Industries, launched Testing Laboratory Software. A few of its features are given below for your references. * Entry Register, Sample Register * Quality Control... - January 17, 2008 - Marg Compusoft Pvt. Ltd.
Anavex Strengthens Board of Directors
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors. - January 16, 2008 - Anavex Life Sciences Corp.
Pharma Diversity Job Board Selects eJobFairs.net as Partner
PharmaDiversity Job Board to offer electronic job fairs powered by eJobFairs.net. - January 11, 2008 - eJobFairs.net LLC
Axium Awarded Phase III Clinical Trial Management Contract for OxThera’s Oxabact™
Axium Healthcare Pharmacy announced today that it has been awarded the clinical trial management contract for OxThera’s Oxabact™. Oxabact™ is manufactured by OxThera. - January 09, 2008 - Axium Healthcare Pharmacy, Inc.
Joint Presentation from Boehringer Ingelheim and Biota at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit (March 5-7, 2008, Philadelphia, PA)
James Chafouleas, Director of Global Licensing – Virology at Boehringer Ingelheim and Leigh Farrell, Vice President of Business Development at Biota will give a joint presentation entitled “Making the Right Deal: It’s Not Just About the Money” at GTCbio’s 5th... - January 09, 2008 - GTCbio
University of Massachusetts to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Eicke Latz, Assistant Professor in Medicine of the Division of Infectious Diseases and Immunology at University of Massachusetts Medical School will give a presentation entitled “Mechanisms of Crystal Recognition by Inflammasomes” at GTCbio’s 6th Cytokines and Inflammation... - January 09, 2008 - GTCbio
Director, Molecular Imaging at GSK to speak at 3rd Imaging in Drug Development conference March 2008
Susanta K. Sarkar, Director of the Molecular Imaging Center of Excellence at GlaxoSmithKline will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Dr. Sarkar will present on molecular imaging approaches to in vivo pharmacokinetic and... - January 09, 2008 - GTCbio
Joint Presentation from Novartis and Human Genome Sciences at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit (March 5-7, 2008, Philadelphia, PA)
Mark Coflin, Global Executive Director of IDTI Alliance Mgmt at Novartis and Margery B. Fischbein, Vice President of Business Development & Strategic Planning at Human Genome Sciences will give a joint presentation at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit taking... - January 09, 2008 - GTCbio
CEO of ChemoCentryx to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Thomas Schall, President & CEO of ChemoCentryx will give a presentation entitled “Inhibition of CCR9 as a Therapeutic Approach: Beyond the Small Intestine” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida.) CCR9 is a chemokine receptor known... - January 09, 2008 - GTCbio
Genentech to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Dimitry M. Danilenko, Senior Pathologist of the Department of Pathology at Genentech will give a presentation entitled “IL-22, a Th17 Cytokine, Plays an Important Role in Psoriasis as well as in Mucocutaneous Host Defense” at GTCbio’s 6th Cytokines and Inflammation (January 28-29,... - January 09, 2008 - GTCbio
Chief, Diagnostic Radiology at NIH to Speak at 3rd Imaging in Drug Development Conference March 2008
Joseph Frank, Chief, Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology at NIH will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Dr. Frank will present on using MRI to monitor cellular therapy. Magnetic labeling of cells... - January 09, 2008 - GTCbio
Biogen-Idec to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Shelia Violette, Director of Discovery Immunology at Biogen-Idec will give a presentation entitled “The Alphavbeta6 Integrin: A Mediator of TGF-Beta Activation and Therapeutic Target in Fibrosis and Oncology” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008,... - January 09, 2008 - GTCbio
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals
Schering Plough to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Jianhua Chao, Principal Scientist of Discovery Chemical Research at Schering-Plough will give a presentation entitled “Potent, Orally Active CXCR2-CXCR1 Antagonists as Anti-inflammatory Therapy” at GTCbio’s 6th Cytokines and Inflammation. (January 28-29, 2008, Orlando,... - January 07, 2008 - GTCbio
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
The U.S. Food and Drug Administration (FDA) has completed its regulatory review of Samaritan's IND (Investigational New Drug) application for Cushing's syndrome SP-6300 and declared it has not identified any deficiencies in its IND filing. Accordingly, Samaritan can proceed with its proposed Phase II clinical study of Cushing's syndrome SP-6300's efficacy in patients experiencing Hypercortisolism. - January 04, 2008 - Samaritan Pharmaceuticals
Matrix Sample Tracking Software is Chosen by Leading Pharmaceutical Company
Matrix Sample Tracking software has been chosen by the Research Division of a major, multi-national pharmaceutical company. It is being implemented at sites in America, Europe and Asia to track samples and slides through the entire pre-clinical, Safety Assessment Division. Peter Mansfield,... - January 04, 2008 - Autoscribe Ltd.
Samaritan Expands Revenue Opportunities with Marketing Authorization Approval for HIV Drug Amphocil in Cyprus
Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health... - January 03, 2008 - Samaritan Pharmaceuticals
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals
EUSA Pharma Signs Exclusive Distribution Agreement with Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals
New Blog Discusses the Globalization and Public Healthcare Policy Trends Affecting the Life Sciences and Health Care Industry
Larry Rothman, a lifelong participant in the health care and pharmaceutical industries, announces the launching of his blog dedicated to the latest trends and issues affecting these sectors. - January 02, 2008 - Larry Rothman's Blog
"Clinical and Economical Considerations for Iv Push Drug Delivery" by Industry Expert Richard Rosenfeld is Now Accessible on Expert411.com for Media and Professional Use
The “Clinical and Economical Considerations For IV Push Drug Delivery” technical paper – authored by Industry Expert Richard Rosenfeld, RPh, MBA, for Baxa Corporation – is now accessible at Expert411.com for media and professional reference. The paper is an overview of the historical background for IV push and a model for implementation of a successful program. - December 27, 2007 - Baxa Corporation
Mark Coflin, Global Executive Director of Business Development and Licensing for Novartis, Has Been Named Princeton Premiers Honored Member in Business
Mark Coflin, Global Executive Director of Business Development and Licensing for Novartis, has been named Princeton Premiers Honored Member in Business. Mark makes his home in East Hanover New Jersey and earned his Bachelors Degree as well as his Masters Degree in Marketing and Finance from the... - December 26, 2007 - Princeton Premier
Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH to Present on Regulation of T Regulatory Cells, January 28, 2008
Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH, will be the honored keynote speaker at the 6th Cytokines and Inflammation conference to be held January 28-29, 2008 in Orlando, FL. Dr. Oppenheim has done many pioneering studies of cytokines including IL-1 and... - December 21, 2007 - GTCbio
VP, GSK and VP, AstraZeneca to Give Keynote Talks at Cancer Drugs Conference
Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug... - December 21, 2007 - GTCbio
CDISC Awards STAR Recognition to Octagon Research Solutions, Inc.
Company recognized for five years of support. - December 20, 2007 - Octagon Research Solutions, Inc
Government Support Injecting Growth in Russian Pharma Industry
Rising health consciousness, growing aging population, and strong government initiatives will drive the growth of Russian Pharma Industry, leading to double-digit growth rate, says the RNCOS report. - December 17, 2007 - RNCOS
Octagon Announces Clinical Data Conversion Milestone
Company completes conversion of 100 studies to CDISC SDTM format. - December 13, 2007 - Octagon Research Solutions, Inc
Baxa Corporation Launches MedBoard™ Medication Tracking System
Baxa announces the introduction of MedBoard, the first wireless medication tracking system. MedBoard is featured at the Baxa booth (no. 2106) at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas, December 3 – 5, 2007. With its dynamic order monitoring, MedBoard reduces waste by identifying time-sensitive orders and ensuring on-time delivery. - December 03, 2007 - Baxa Corporation
Samaritan Presented Favorable Caprospinol Data at Alzheimer's Drug Development Summit
In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals
Princeton Premier Honors Mr. Han de Min with Inclusion in the 2007-2008 Princeton Premier Registry
Princeton Premier Honors Mr. Han de Min With Inclusion in the 2007-2008 Princeton Premier Registry. Han is currently serving as a vice president for Aspen Technology and has been doing so for over a year. He currently acts as a consultant on strategic business planning. Han is a respected member... - November 27, 2007 - Princeton Premier
Thomas Waldmann, Chief, NCI to Give Keynote Talk at Immunodiagnostics & Immunomonitoring Conference
Thomas Waldmann, Chief of Metabolism & Head of Cytokine Immunology/ Immunotherapy at NCI to give keynote presentation at 2nd Immunodiagnostics & Immunomonitoring conference December 6-7, 2007 - November 22, 2007 - GTCbio
OptimizeRx Helps Patients Save on Rising Prescription Costs
Tens of thousands of patients have visited the OPTIMIZERx website (www.optimizerx.com) to save on their rising out-of-pocket costs for prescription medications since its launch in January 2007. “We are very pleased by the large number of patients who have come to OPTIMIZERx and discovered... - November 18, 2007 - OptimizeRx
New Internet Solution Enables Pharmaceutical Manufacturers to Improve Access, Adherence and Brand Loyalty
A new Internet service called OPTIMIZERx (www.optimizerx.com) will now allow pharmaceutical manufacturers to help patients better afford and comply with their prescribed brand medications. The pharmaceutical industry has come under increased pressure for the high cost of prescription medications, and major efforts are being made to steer patients towards the use of generic prescription medications. - November 18, 2007 - OptimizeRx
New Internet Site Helps Patients with Rising Prescription Drug Costs
A free, new Internet site called OPTIMIZERx (www.optimizerx.com) is now available to help the majority of patients reduce their rising costs for prescription medications. With escalating costs now being passed on to patients, many Americans are finding out the hard way that even with healthcare insurance, they are not immune to the rising cost of prescription medication. - November 15, 2007 - OptimizeRx
Octagon Announces ViewPoint(R) for Document Management
Octagon Research Solutions, Inc. announces ViewPoint(R) for document management. New solution supports the entire document lifecycle from authoring to submission. - November 14, 2007 - Octagon Research Solutions, Inc
Robert Copeland, VP, Oncology Drug Discovery, GSK to Give Keynote Talk at Cancer Drugs Conference
Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug... - November 11, 2007 - GTCbio
Pfizer, Novartis, and AstraZeneca to Give Featured Presentations at Oncology Biomarkers Conference
Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008. - November 11, 2007 - GTCbio
Octagon Research Solutions, Inc., Inducted in the Philadelphia 100 Hall of Fame
Octagon Research Solutions, Inc. and its Chairman and CEO, James C. Walker and Octagon Research Solutions, Inc. have been inducted in the Philadelphia 100 Hall of Fame. - November 03, 2007 - Octagon Research Solutions, Inc
Octagon Research Solutions, Inc. Ranked as One of the Fastest Growing Companies in North America on Deloitte’s 2007 Technology Fast 500
Octagon ranked number 424 on Deloitte’s 2007 Technology Fast 500. - November 02, 2007 - Octagon Research Solutions, Inc